Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-476
Closed -$36K 2933
2026
Q1
$36K Sell
476
-8
-2% -$601 ﹤0.01% 497
2025
Q4
$36.1K Buy
484
+16
+3% +$1.17K ﹤0.01% 467
2025
Q3
$31.6K Buy
468
+362
+342% +$24K ﹤0.01% 448
2025
Q2
$6.91K Sell
106
-4
-4% -$240 ﹤0.01% 373
2025
Q1
$6.8K Sell
110
-1
-0.9% -$66 ﹤0.01% 408
2024
Q4
$8K Sell
111
-7
-6% -$547 ﹤0.01% 374
2024
Q3
$9.61K Buy
118
+1
+0.9% +$80 ﹤0.01% 375
2024
Q2
$8.69K Hold
117
﹤0.01% 352
2024
Q1
$9.12K Buy
117
+2
+2% +$149 ﹤0.01% 364
2023
Q4
$8.22K Sell
115
-7
-6% -$487 ﹤0.01% 310
2023
Q3
$8.47K Sell
122
-22
-15% -$1.66K ﹤0.01% 302
2023
Q2
$11.7K Sell
144
-4
-3% -$327 ﹤0.01% 261
2023
Q1
$11.9K Buy
148
+8
+6% +$644 ﹤0.01% 269
2022
Q4
$10.5K Buy
140
+9
+7% +$641 ﹤0.01% 283
2022
Q3
$8K Buy
+131
New +$9.07K ﹤0.01% 303
2022
Q1
$16K Sell
206
-68
-25% -$4.89K ﹤0.01% 329
2021
Q4
$21K Buy
+274
New +$20.1K 0.01% 266

Other funds holding HOLX

SJS Investment Consulting's HOLX Position: Q2 2026 in Review

SJS Investment Consulting sold out of Hologic (HOLX) in Q2 2026, closing a stake of 476 shares — an estimated $36K sold.

SJS Investment Consulting first reported a position in HOLX in Q4 2021 and held it in 17 quarters. The position peaked at $36.1K in Q4 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • SJS Investment Consulting reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • SJS Investment Consulting sold 476 Hologic shares in Q2 2026, an estimated $36K.
  • SJS Investment Consulting first reported a position in Hologic in Q4 2021 and held it in 17 quarters.
  • SJS Investment Consulting's Hologic position peaked at $36.1K in Q4 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.